Welcome to Recap Consulting. For over 15 years, we have been providing our clients with expert advice and in-depth analysis in the areas of alliance structuring and deal valuation in the pharmaceutical and biotech industries. Our consulting expertise has been retained to assist in hundreds of biotech transactions with a total value to date of over $7 billion.
Recap’s data services, accessible at www.recap.com and www.rdna.com, have proven to be an invaluable asset to over 1,500 companies operating and involved in the biotech arena. Our Alliances Database is the most extensive source for information on worldwide partnering and business development, offering information on biotech alliances, with contracts and deal analyses prepared by our analyst staff.
Recap Consulting maintains independent and confidential client relations with major pharmaceutical and biotech companies, start-up biotechs, venture capital funds, investment banks, law firms, consultancies and universities. Our history, experience, and access to premium data make us an essential resource to our clients as we are uniquely able to provide expert opinions, supported by documented analyses, on biotechnology alliances and industry trends.
|
|